Narrow Opening for Appeals
Court of Appeals Leaves Narrow Opening for Certain IPR Appeals Last month, the Court of Appeals for the Federal Circuit dismissed an appeal in a case involving Janssen and Mylan. Janssen had filed PIV cases against Teva and Mylan involving the 9,439,906 patent covering Invega Sustenna®(paliperidone). Mylan filed a Petition for Inter Partes Review challenging … Continue reading →